Pictet Asset Management Holding Sa Avidity Biosciences, Inc. Transaction History
Pictet Asset Management Holding Sa
- $88.9 Billion
- Q4 2024
A detailed history of Pictet Asset Management Holding Sa transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 799,028 shares of RNA stock, worth $26.6 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
799,028
Previous 786,480
1.6%
Holding current value
$26.6 Million
Previous $36.1 Million
35.68%
% of portfolio
0.03%
Previous 0.04%
Shares
4 transactions
Others Institutions Holding RNA
# of Institutions
257Shares Held
100MCall Options Held
517KPut Options Held
717K-
Price T Rowe Associates Inc Baltimore, MD11MShares$368 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.43MShares$314 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$287 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.93MShares$264 Million3.76% of portfolio
-
Avoro Capital Advisors LLC New York, NY7.5MShares$250 Million3.18% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.74B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...